HomeHRMY • NASDAQ
Harmony Biosciences Holdings Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 239.46M | 28.71% |
Operating expense | 114.32M | 40.18% |
Net income | 50.87M | 10.35% |
Net profit margin | 21.24 | -14.29% |
Earnings per share | 1.08 | 4.85% |
EBITDA | 71.46M | 5.58% |
Effective tax rate | 24.63% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 672.58M | 63.85% |
Total assets | 1.21B | 30.18% |
Total liabilities | 373.10M | 12.60% |
Total equity | 835.12M | — |
Shares outstanding | 57.60M | — |
Price to book | 2.34 | — |
Return on assets | 14.14% | — |
Return on capital | 16.78% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 50.87M | 10.35% |
Cash from operations | 108.73M | 54.23% |
Cash from investing | -4.79M | -742.82% |
Cash from financing | -3.00M | -154.98% |
Net change in cash | 100.95M | 44.07% |
Free cash flow | 57.45M | -15.39% |
Previous close
$33.99
Day range
$32.77 - $34.04
Year range
$25.52 - $40.93
Market cap
1.91B USD
Avg Volume
889.13K
P/E ratio
10.37
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Website
Employees
268